Sort by
Refine Your Search
-
candidates wishing to work flexibly. *PhD candidates who are close to completion and have not yet received their PhD award, will be appointed on a salary of £37,889 - £38,483. On providing a copy of the formal
-
to refereed journals, and work with and help supervise BSc, MSci, and PhD students. The successful applicant will have a PhD in Astrophysics, Theoretical Physics, or a related discipline and prior experience
-
motivated and detail-oriented scientist with a PhD (or close to completion*) in Cell Biology/Molecular Genetics, or a related field. You should have a background in telomere biology, centrosome function, and
-
and have not yet received their PhD award, will be appointed on a salary of £38,483. On providing a copy of the formal award letter or award certificate, the salary will increase to £41,510.
-
candidates wishing to work flexibly. *PhD candidates who are close to completion and have not yet received their PhD award, will be appointed on a salary of £37,889 - £38,483. On providing a copy of the formal
-
are close to completion and have not yet received their PhD award, will be appointed on a salary of £37,889 - £38,483. On providing a copy of the formal award letter or award certificate, the salary will
-
flexibly. *PhD candidates who are close to completion and have not yet received their PhD award, will be appointed on a salary of £37,889 - £38,483. On providing a copy of the formal award letter or award
-
PhD in a relevant field (or be close to completion**) and be able to work independently and collaboratively within a team, with a strong background in cell culture and/or tuberculosis research
-
care using Eppi Reviewer software and writing of evidence briefings for Integrated Care Systems based on the Living Map. The role is an exciting opportunity to combine evaluation skills with policy and
-
computational methods. You will not only employ cutting-edge multi-omics analysis pipelines but also develop new computational techniques to study cellular communication and investigating new targets for drugs re